Label: DAYCLEAR ALLERGY RELIEF CHEWABLES- chlophedianol hydrochloride, pyrilamine maleate tablet, chewable

  • NDC Code(s): 58809-222-24
  • Packager: GM Pharmaceuticals, INC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated January 14, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    DayClear Allergy Relief Chewable

    Drug Facts

  • Active ingredients (in each tablet)

    Chlophedianol HCl 25 mg

    Pyrilamine Maleate 25 mg

  • Purpose

    Cough Suppressant

    Antihistamine

  • Uses

    ■ temporarily relieves these symptoms

    due to the common cold, hay fever, or other upper respiratory allergies:

    ■ itchy nose or throat   ■ sneezing   

    ■ itchy, watery eyes   ■ runny nose

    ■ cough due to minor throat and

    bronchial irritation

  • Warnings

    Ask a doctor before use if you have

    ■ a cough that lasts or is chronic such as occurs with smoking, asthma, or emphysema

    ■ glaucoma

    ■ difficulty in urination due to enlargement of the prostate gland

    ■ cough that occurs with too much phlegm (mucus)

    ■ a breathing problem such as emphysema or chronic bronchitis

    Ask a doctor before use

    if you are taking sedative or tranquilizers

    When using this product

    ■ do not use more than directed

    ■ marked drowsiness may occur

    ■ avoid alcoholic drinks

    ■ alcohol, sedatives, and tranquilizers may increase drowsiness

    ■ be careful when driving a motor vehicle or operating machinery

    ■ excitability may occur, especially in children

    Stop use and ask a doctor if

    ■ nervousness, dizziness, or sleeplessness occurs

    ■ symptoms do not improve within 7 days, tend to recur, or are accompanied by a fever, rash or persistent headache. A persistent cough may be a sign of a serious condition

    ■ new symptoms occur

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    ■ do not exceed 4 doses per 24-hour period

    ■ adults and children 12 years and older: chew 1 tablet every 6 to 8 hours

    ■ children under 12 years:       do not use

  • Other information

    ■ read all product information before using

    ■ store at room temperature 20-30°C (68-86°F)

  • Inactive ingredients

    crospovidone, flavor, L-menthol, magnesium stearate, mannitol, microcrystalline cellulose, silicon dioxide, stearic acid, stevia, sucralose

  • Questions or comments?

    Call 1-888-535-0305 9 a.m. - 5 p.m. CST.

  • PRINCIPAL DISPLAY PANEL

    NDC 58809-222-24
    DayClear
    Allergy
    Relief
    Chewables
    24 Chewable Tablets

    PRINCIPAL DISPLAY PANEL NDC 58809-222-24 DayClear Allergy Relief Chewables 24 Chewable Tablets

  • INGREDIENTS AND APPEARANCE
    DAYCLEAR ALLERGY RELIEF CHEWABLES 
    chlophedianol hydrochloride, pyrilamine maleate tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58809-222
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CHLOPHEDIANOL HYDROCHLORIDE (UNII: 69QQ58998Y) (CHLOPHEDIANOL - UNII:42C50P12AP) CHLOPHEDIANOL HYDROCHLORIDE25 mg
    PYRILAMINE MALEATE (UNII: R35D29L3ZA) (PYRILAMINE - UNII:HPE317O9TL) PYRILAMINE MALEATE25 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSPOVIDONE (UNII: 2S7830E561)  
    LEVOMENTHOL (UNII: BZ1R15MTK7)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MANNITOL (UNII: 3OWL53L36A)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    STEVIA REBAUDIUNA LEAF (UNII: 6TC6NN0876)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    Product Characteristics
    ColorwhiteScoreno score
    ShapeROUNDSize10mm
    FlavorMINTImprint Code DC
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58809-222-241 in 1 CARTON01/02/2020
    124 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34101/02/2020
    Labeler - GM Pharmaceuticals, INC (793000860)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!